BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 25789973)

  • 1. Novel function of cytoplasmic p53 at the interface between mitochondria and the endoplasmic reticulum.
    Kroemer G; Bravo-San Pedro JM; Galluzzi L
    Cell Death Dis; 2015 Mar; 6(3):e1698. PubMed ID: 25789973
    [No Abstract]   [Full Text] [Related]  

  • 2. p53 orchestrates calcium signaling in vivo.
    Sorrentino G; Comel A; Del Sal G
    Cell Cycle; 2015; 14(9):1343-4. PubMed ID: 25880696
    [No Abstract]   [Full Text] [Related]  

  • 3. The Parkinson disease-related protein DJ-1 counteracts mitochondrial impairment induced by the tumour suppressor protein p53 by enhancing endoplasmic reticulum-mitochondria tethering.
    Ottolini D; Calì T; Negro A; Brini M
    Hum Mol Genet; 2013 Jun; 22(11):2152-68. PubMed ID: 23418303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytoplasmic functions of the tumour suppressor p53.
    Green DR; Kroemer G
    Nature; 2009 Apr; 458(7242):1127-30. PubMed ID: 19407794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The BARD1 BRCT domain contributes to p53 binding, cytoplasmic and mitochondrial localization, and apoptotic function.
    Tembe V; Martino-Echarri E; Marzec KA; Mok MT; Brodie KM; Mills K; Lei Y; DeFazio A; Rizos H; Kettle E; Boadle R; Henderson BR
    Cell Signal; 2015 Sep; 27(9):1763-71. PubMed ID: 26022179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endoplasmic reticulum-mitochondria Ca
    Missiroli S; Danese A; Iannitti T; Patergnani S; Perrone M; Previati M; Giorgi C; Pinton P
    Biochim Biophys Acta Mol Cell Res; 2017 Jun; 1864(6):858-864. PubMed ID: 28064002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cytoplasmic side of p53's oncosuppressive activities.
    Comel A; Sorrentino G; Capaci V; Del Sal G
    FEBS Lett; 2014 Aug; 588(16):2600-9. PubMed ID: 24747877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell death decision by p53 via control of the mitochondrial membrane.
    Dashzeveg N; Yoshida K
    Cancer Lett; 2015 Oct; 367(2):108-12. PubMed ID: 26231733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytoplasmic destruction of p53 by the endoplasmic reticulum-resident ubiquitin ligase 'Synoviolin'.
    Yamasaki S; Yagishita N; Sasaki T; Nakazawa M; Kato Y; Yamadera T; Bae E; Toriyama S; Ikeda R; Zhang L; Fujitani K; Yoo E; Tsuchimochi K; Ohta T; Araya N; Fujita H; Aratani S; Eguchi K; Komiya S; Maruyama I; Higashi N; Sato M; Senoo H; Ochi T; Yokoyama S; Amano T; Kim J; Gay S; Fukamizu A; Nishioka K; Tanaka K; Nakajima T
    EMBO J; 2007 Jan; 26(1):113-22. PubMed ID: 17170702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of oxidored-nitro domain containing protein 1 inhibits human nasopharyngeal carcinoma and cervical cancer cell proliferation and induces apoptosis: Involvement of mitochondrial apoptotic pathways.
    Ouyang J; Wu M; Huang C; Cao L; Li G
    Oncol Rep; 2013 Jan; 29(1):79-86. PubMed ID: 23124592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytoplasmic organelles on the road to mRNA decay.
    Weil D; Hollien J
    Biochim Biophys Acta; 2013; 1829(6-7):725-31. PubMed ID: 23337852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential contribution of Puma and Noxa in dual regulation of p53-mediated apoptotic pathways.
    Shibue T; Suzuki S; Okamoto H; Yoshida H; Ohba Y; Takaoka A; Taniguchi T
    EMBO J; 2006 Oct; 25(20):4952-62. PubMed ID: 17024184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Negative regulation of beta4 integrin transcription by homeodomain-interacting protein kinase 2 and p53 impairs tumor progression.
    Bon G; Di Carlo SE; Folgiero V; Avetrani P; Lazzari C; D'Orazi G; Brizzi MF; Sacchi A; Soddu S; Blandino G; Mottolese M; Falcioni R
    Cancer Res; 2009 Jul; 69(14):5978-86. PubMed ID: 19567674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Taking up the reins of power: metabolic functions of p53.
    Humpton T; Vousden KH
    J Mol Cell Biol; 2019 Jul; 11(7):610-614. PubMed ID: 31282931
    [No Abstract]   [Full Text] [Related]  

  • 15. Cancer biology: can less be more for p53?
    Berns A
    Nature; 2006 Sep; 443(7108):153-4. PubMed ID: 16971934
    [No Abstract]   [Full Text] [Related]  

  • 16. Understanding p53: new insights into tumor suppression.
    Kawauchi K; Wolf SJ
    Expert Rev Anticancer Ther; 2014 Oct; 14(10):1101-3. PubMed ID: 25119697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hsp70 family member, mot-2/mthsp70/GRP75, binds to the cytoplasmic sequestration domain of the p53 protein.
    Wadhwa R; Yaguchi T; Hasan MK; Mitsui Y; Reddel RR; Kaul SC
    Exp Cell Res; 2002 Apr; 274(2):246-53. PubMed ID: 11900485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age activator.
    Novak K
    Nat Rev Cancer; 2002 Feb; 2(2):81. PubMed ID: 12635170
    [No Abstract]   [Full Text] [Related]  

  • 19. p53 antagonizes the unfolded protein response and inhibits ground glass hepatocyte development during endoplasmic reticulum stress.
    Dioufa N; Chatzistamou I; Farmaki E; Papavassiliou AG; Kiaris H
    Exp Biol Med (Maywood); 2012 Oct; 237(10):1173-80. PubMed ID: 23038705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomic and transcriptomic study on the action of a cytotoxic saponin (Polyphyllin D): induction of endoplasmic reticulum stress and mitochondria-mediated apoptotic pathways.
    Siu FM; Ma DL; Cheung YW; Lok CN; Yan K; Yang Z; Yang M; Xu S; Ko BC; He QY; Che CM
    Proteomics; 2008 Aug; 8(15):3105-17. PubMed ID: 18615425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.